Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
KALA	Kala Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.98M	n/a	-385.6%	n/a	-$3.31
KAPA	Kairos Pharma, Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.45M	n/a	-85.9%	n/a	-$0.30
KNSA	Kiniksa Pharmaceuticals International, plc Manufacturing · Year ended 2025-12-31 · USD	$677.56M	$59.01M	8.7%	10.4%	60.1%	$0.75
KPRX	Kiora Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.84M	n/a	-67.2%	-100.0%	-$2.64
KPTI	Karyopharm Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$146.07M	-$196.04M	-134.2%	n/a	0.6%	-$17.93
KROS	Keros Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$244.06M	$87.01M	35.7%	28.7%	n/m	$2.30
KRRO	Korro Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.39M	-$117.26M	n/m	-228.0%	181.5%	-$12.48
KRSA	Korsana Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.07M	-$3.53M	-170.1%	-38.8%	3.7%	-$1.11
KTTA	Pasithea Therapeutics Corp. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.43M	n/a	-37.0%	n/a	-$2.91
KURA	Kura Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$67.48M	-$278.67M	-412.9%	-160.0%	25.2%	-$3.18
KYNB	Kyntra Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$183.45M	n/a	n/a	n/a	$45.37
LAB	Standard Biotools Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.33M	-$74.90M	-87.8%	-17.7%	-6.2%	-$0.20
LBRX	LB Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.20M	n/a	-8.4%	n/a	-$3.13
LEXX	Lexaria Bioscience Corp. Manufacturing · Year ended 2025-08-31 · USD	$705.9K	-$11.90M	n/m	-398.1%	52.0%	-$0.66
LFCR	Lifecore Biomedical, Inc. Manufacturing · Year ended 2025-05-25 · USD	$128.87M	-$38.72M	-30.0%	n/m	0.5%	-$1.27
LFVN	Lifevantage Corp Manufacturing · Year ended 2026-06-30 · USD	$182.59M	$5.07M	2.8%	15.1%	-20.1%	$0.40
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
LIFD	Lftd Partners Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.92M	-$24.86M	-67.3%	-196.8%	-1.1%	-$1.68
LITS	Lite Strategy, Inc. Manufacturing · Year ended 2025-06-30 · USD	$0	-$15.95M	n/a	-94.2%	-100.0%	-$2.39
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
LNAI	Lunai Bioworks Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$178.01M	n/a	n/a	n/a	-$1.08
LPCN	Lipocine Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.98M	-$9.63M	-487.1%	-66.5%	-82.3%	-$1.69
LQDA	Liquidia Corp Manufacturing · Year ended 2025-12-31 · USD	$158.32M	-$68.92M	-43.5%	-154.0%	n/m	-$0.80
LRMR	Larimar Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$165.67M	n/a	-212.2%	n/a	n/a

Rows per page: 2550 100